Changes in Tumor Stem Cell Markers and Epithelial-Mesenchymal Transition Markers in Nonluminal Breast Cancer after Neoadjuvant Chemotherapy and Their Correlation with Contrast-Enhanced Ultrasound

Figure 1

Contrast-enhanced ultrasound measurement of nonluminal breast cancer with nonconcentric shrink mode before and after NAC. (a) Left, two-dimensional ultrasound image of the lesion before NAC; right, ultrasound contrast image of the lesion before NAC; (b) Left, two-dimensional ultrasound image of the lesion after NAC; right, ultrasound contrast image of the lesion after NAC.

(a)

(b)